Committed to sharing our science

Committed to sharing our science

335 results available

Safety, Efficacy, and Quantitative Understanding of Obstruction, Impact of Aficamten in Hypertrophic Cardiomyopathy (SEQUOIA-HCM) Study Design: A Phase 3 Study

Poster, HFSA 2022 Annual Scientific Meeting
Coats C, et al
Washington, DC
October 1, 2022
Withdrawal of Background Standard of Care Medical Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in REDWOOD HCM OLE

Presentation, 2022 HCM Society Scientific Sessions
Masri A, et al
National Harbor, MD
September 30, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants

JACC: Basic to Translational Science
Malik FI, et al
August 10, 2022
Characterizing Hospitalization as an Outcome Measure in ALS Clinical Trials

Poster, European Network for the Cure of ALS (ENCALS), 2022
Simmons Z, et al
Edinburgh, UK
June 1, 2022
Sudden Changes in the ALSFRS-R in Three ALS Clinical Trials

Poster, European Network for the Cure of ALS (ENCALS), 2022
Shefner JM, et al
Edinburgh, UK
June 1, 2022